These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone histology in CAPD patients: a comparison with hemodialysis and conservatively treated chronic uremics. Joffe P, Pódenphant J, Heaf JG. Adv Perit Dial; 1989 Sep; 5():171-6. PubMed ID: 2577405 [Abstract] [Full Text] [Related]
3. Bone mineral and aluminum concentrations in patients undergoing CAPD. Giangrande A, Costanini S, Ballanti P, Castiglioni A, Caligara F, Pisoni B, Giordano R, Vernillo I, Berni S, Bonucci E. Adv Perit Dial; 1992 Sep; 8():351-5. PubMed ID: 1361821 [Abstract] [Full Text] [Related]
4. Low turnover bone disease is the more common form of bone disease in CAPD patients. Rodriguez-Perez JC, Plaza C, Torres A, Vega N, Anabitarte A, Fernandez A, Lorenzo V, Hortal L, Palop L. Adv Perit Dial; 1992 Sep; 8():376-80. PubMed ID: 1361827 [Abstract] [Full Text] [Related]
5. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis. Buccianti G, Bianchi ML, Valenti G. Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771 [Abstract] [Full Text] [Related]
6. Differences in calcium kinetic pattern between CAPD and HD patients. Kurz P, Tsobanelis T, Roth P, Werner E, Ewald U, Grützmacher P, Schoeppe W, Vlachojannis J. Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126 [Abstract] [Full Text] [Related]
7. Bone biopsy results and serum bone turnover parameters in uremic children. Ziólkowska H, Pańiczyk-Tomaszewska M, Debiński A, Polowiec Z, Sawicki A, Sieniawska M. Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959 [Abstract] [Full Text] [Related]
8. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Coburn JW. Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845 [No Abstract] [Full Text] [Related]
9. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Aloni Y, Shany S, Chaimovitz C. Miner Electrolyte Metab; 1983 Feb; 9(2):82-6. PubMed ID: 6601753 [Abstract] [Full Text] [Related]
10. Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide. Hercz G, Andress DL, Nebeker HG, Shinaberger JH, Sherrard DJ, Coburn JW. Am J Kidney Dis; 1988 Jan; 11(1):70-5. PubMed ID: 3337101 [Abstract] [Full Text] [Related]
11. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. Mottet JJ, Horber FF, Casez JP, Descoeudres C, Jaeger P. J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702 [Abstract] [Full Text] [Related]
12. Vitamin D therapy in CAPD: what is its role? Hutchison AJ, Gokal R. Adv Perit Dial; 1993 Jan; 9():253-6. PubMed ID: 8105937 [Abstract] [Full Text] [Related]